Back
G1 Therapeutics Stock Price Chart

Doing This Wins 85% Of Market Trades
Click Here To See How It Works
Sell
19
GTHX
G1 Therapeutics
Last Price:
2.62
Seasonality Move:
34.99%
7 Day Trial
ALL ACCESS PASS
$
7

July 1: Every Printed Dollar is at Risk...
Details Here...- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and GTHX is experiencing selling pressure, which indicates risk of future bearish movement.
G1 Therapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 2.79 | Sell |
20-day SMA: | 2.88 | Sell |
50-day SMA: | 2.77 | Sell |
200-day SMA: | 7.17 | Sell |
8-day EMA: | 2.77 | Sell |
20-day EMA: | 2.81 | Sell |
50-day EMA: | 3.08 | Sell |
200-day EMA: | 5.73 | Sell |
G1 Therapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.04 | Sell |
Relative Strength Index (14 RSI): | 41.54 | Sell |
Chaikin Money Flow: | -325328 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (2.66 - 3) | Sell |
Bollinger Bands (100): | (2.26 - 5.74) | Sell |
G1 Therapeutics Technical Analysis
May-15 | May-16 | May-17 | May-18 | May-19 | May-22 | May-23 | May-24 | May-25 | May-26 | |
---|---|---|---|---|---|---|---|---|---|---|
May | ||||||||||
15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | 25 | 26 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for G1 Therapeutics Stock
Is G1 Therapeutics Stock a Buy?
- G1 Therapeutics share price is 2.62 while GTHX 8-day simple moving average is 2.79, which is a Sell signal.
- The stock price of GTHX is 2.62 while G1 Therapeutics 20-day SMA is 2.88, which makes it a Sell.
- G1 Therapeutics 50-day simple moving average is 2.77 while GTHX share price is 2.62, making it a Sell technically.
- GTHX stock price is 2.62 and G1 Therapeutics 200-day simple moving average is 7.17, creating a Sell signal.
GTHX Technical Analysis vs Fundamental Analysis
Sell
19
G1 Therapeutics (GTHX)
is a Sell
Is G1 Therapeutics a Buy or a Sell?
-
G1 Therapeutics stock is rated a Sell
The current G1 Therapeutics [GTHX] share price is $2.62. The Score for GTHX is 19, which is 62% below its historic median score of 50, and infers higher risk than normal.
G1 Therapeutics Stock Info
Market Cap:
135.35M
Price in USD:
2.62
Share Volume:
542.21K
G1 Therapeutics 52-Week Range
52-Week High:
17.49
52-Week Low:
2.38
Sell
19
G1 Therapeutics (GTHX)
is a Sell
G1 Therapeutics Share Price Forecast
-
What is the G1 Therapeutics stock price today?
The G1 Therapeutics stock price is 2.62 USD today. -
Will GTHX stock go up or go down?
G1 Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is G1 Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, G1 Therapeutics is overvalued.
Is G1 Therapeutics Stock a Buy?
- G1 Therapeutics share price is 2.62 while GTHX 8-day exponential moving average is 2.77, which is a Sell signal.
- The stock price of GTHX is 2.62 while G1 Therapeutics 20-day EMA is 2.81, which makes it a Sell.
- G1 Therapeutics 50-day exponential moving average is 3.08 while GTHX share price is 2.62, making it a Sell technically.
- GTHX stock price is 2.62 and G1 Therapeutics 200-day simple moving average is 5.73, creating a Sell signal.
Fundamental Analysis of G1 Therapeutics
Is G1 Therapeutics a good investment?
- Analysts estimate an earnings increase this quarter of $0.59 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.92 per share, and an increase next year of $0.42 per share.
Technical Analysis of G1 Therapeutics
Should I short G1 Therapeutics stock?
- GTHX Moving Average Covergence Divergence (MACD) indicator is -0.04, suggesting G1 Therapeutics is a Sell
- G1 Therapeutics Relative Strength Index (RSI) is 41.54, which suggest G1 Therapeutics is oversold
- The Bollinger Bands (25) for G1 Therapeutics is (2.66 - 3), which suggest G1 Therapeutics is a Sell
- The Bollinger Bands (100) for G1 Therapeutics is (2.26 - 5.74), which suggest G1 Therapeutics is a Sell
* G1 Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.